About ResMed, Inc. 
ResMed, Inc.
Pharmaceuticals & Biotechnology
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Company Coordinates 
Company Details
9001 Spectrum Center Blvd , SAN DIEGO CA : 92123-1438
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 154 Schemes (30.51%)
Foreign Institutions
Held by 395 Foreign Institutions (19.78%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Dr. Peter Farrell
Non-Executive Chairman of the Board
Mr. Michael Farrell
Chief Executive Officer, Director
Mr. Ronald Taylor
Lead Independent Director
Ms. Carol Burt
Independent Director
Mr. Jan De Witte
Independent Director
Ms. Karen Drexler
Independent Director
Revenue and Profits:
Net Sales:
1,348 Million
(Quarterly Results - Jun 2025)
Net Profit:
380 Million
Pharmaceuticals & Biotechnology
USD 52,609 Million (Mid Cap)
36.00
NA
2.45%
-0.09
23.36%
8.82






